TGF-β1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner

Keyphrases

• Cyclooxygenase-2 100%
• Astrocytic 100%
• Nitric Oxide Synthase 2 100%
• Astrocytes 50%
• Lipopolysaccharide 37%
• Inflammatory Genes 25%
• Interferon-α (IFN-α) 25%
• NOS2 25%
• Neurological Diseases 12%
• Biological Outcomes 12%
• Changes in Gene Expression 12%
• Interleukin-1β 12%
• Stimulus Specificity 12%
• MRNA Expression 12%
• Inflammatory Mediators 12%
• Protein Expression Level 12%
• Nitric Oxide Production 12%
• Protein Expression 12%
• Lieu 12%
• Cell Population 12%

Biochemistry, Genetics and Molecular Biology

• Cyclooxygenase 100%
• Nitric Oxide Synthase 100%
• Astrocyte 50%
• Lipopolysaccharide 37%
• interferon 25%
• Interferon 25%
• Nitric Oxide 12%
• Interleukin-1 12%
• Mediator 12%
• Tumor Necrosis Factor 12%
• Protein Expression Level 12%
• Messenger RNA 12%

Neuroscience

• Cyclooxygenase 2 100%
• Inducible Nitric Oxide Synthase 100%
• Astrocyte 50%
• Lipopolysaccharide 37%
• Protein Expression 25%
• Interferon 25%
• Nitric Oxide 12%
• Nervous System Disorder 12%